6 research outputs found

    Sense and nonsense in sensors

    Get PDF
    Continuous subcutaneous glucose monitoring (CGM) is a developing technology in the treatment of diabetes mellitus. The first randomised controlled trials on its efficacy have been performed. In several studies, CGM lowered HbA1c in adult patients with suboptimally controlled type 1 diabetes mellitus, when selecting compliant patients who tolerate the device. However, as a preventive tool for hypoglycaemia, CGM has not fulfilled the great expectations. Increasing reimbursement of CGM is expected in the near future, awaiting studies on cost-effectiveness

    From Renal Tissue Slices to Membrane Vesicles

    No full text

    Diagnosis, Evaluation, and Medical Management of Obesity and Diabetes

    No full text

    A compendium of solid-phase chemistry publications

    No full text
    corecore